Skip to main content
SpringerLink
Log in

Drug–Nutrient Interactions in Transplantation

  • Chapter
  • First Online:
Handbook of Drug-Nutrient Interactions

Part of the book series: Nutrition and Health ((NH))

  • 2878 Accesses

Objectives

• Update developments within the field of transplant drug–nutrient interactions.

• Describe the biology of immunosuppressive medications used for transplantation.

• Evaluate the nutritional impairments associated with solid organ transplantation.

Offer recommendations to health-care providers caring for these medically complex patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. McPartland KJ, Pomposelli, JJ. Update on immunosuppressive drugs used in solid-organ transplantation and their nutrition implications. Nutr Clin Pract 2007;22(5):467–473.

    Article  Google Scholar 

  2. Hasse JM. Nutrition assessment and support of organ transplant recipients. JPEN J Parenter Enteral Nutr 2001;25(3):120–131.

    Article  CAS  Google Scholar 

  3. Weiss M, Armenti V, Hasse J. Drug-Nutrient Interactions in Transplantation, in Handbook of Drug-Nutrient Interactions. In: Boullata J, Armenti V, eds. Totowa, NJ: Humana Press Inc., 2004:425–440.

    Google Scholar 

  4. Hale DA. Basic transplantation immunology. Surg Clin North Am 2006;86(5):1103–1125.

    Article  Google Scholar 

  5. Lin S, Cosgrove CJ. Perioperative management of immunosuppression. Surg Clin North Am 2006;86(5):1167–1183.

    Article  Google Scholar 

  6. Hasse J. Nutritional aspects of adult liver transplantation. In: Klintmalm GB, Bussittil RW, ed. Transplantation of the liver, 2nd ed. Philadelphia, PA: Elsevier Saunders, 2005:491–505.

    Google Scholar 

  7. Magliocca JF, Knechtle SJ. The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int 2006;19(9):705–714.

    Article  CAS  Google Scholar 

  8. Halloran PF, Gourishankar S. Principles and overview of immunosuppression. In: Norman DJ, Turka LA, ed. Primer on Transplantation, 2nd ed. Mount Laurel, NJ: American Society of Transplantation, 2001:87–98.

    Google Scholar 

  9. Ildstad ST. Transplantation immunology and immunosuppression. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston textbook of surgery: the biological basis of modern surgical practice, 18th ed. Philadelphia, PA: Saunders, 2007:665–697.

    Google Scholar 

  10. Hasse J. Nutritional issues in adult organ transplantation. In: Cupples SA, Ohler L, eds. Solid organ transplantation: a handbook for primary health care providers. New York: Springer, 2002:64–87.

    Google Scholar 

  11. Kobashigawa JA, Kasiske BL. Hyperlipidemia in solid organ transplantation. Transplantation 1997;63(3):331–338.

    Article  CAS  Google Scholar 

  12. Markell M. New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am J Kidney Dis 2004;43(6):953–965.

    Article  Google Scholar 

  13. Boudreaux JP, et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987;44(3):376–381.

    Article  CAS  Google Scholar 

  14. Cosio FG, et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002;62(4):1440–446.

    Article  Google Scholar 

  15. Fernandez-Fresnedo G, et al. Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients. Transplant Proc 2003;35(2):700.

    Article  CAS  Google Scholar 

  16. Garlicki M. Post-transplant diabetes mellitus (PTDM) in heart recipients. Ann Transplant 2005;10(3):51–53.

    Google Scholar 

  17. Kasiske BL, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003;3(2):178–185.

    Article  Google Scholar 

  18. Miles AM, et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation 1998;65(3):380–384.

    Article  CAS  Google Scholar 

  19. Moore R, et al. Diabetes mellitus in transplantation: 2002 consensus guidelines. Transplant Proc 2003;35(4):1265–1270.

    Article  CAS  Google Scholar 

  20. Revanur VK, et al. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001;15(2):89–94.

    Article  CAS  Google Scholar 

  21. Roth D, et al. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation 1989;47(2):278–281.

    Article  CAS  Google Scholar 

  22. Steinmuller TH, et al. Liver transplantation and diabetes mellitus. Exp Clin Endocrinol Diabetes, 2000;108(6):401–405.

    Article  CAS  Google Scholar 

  23. Stockmann M, et al. Posttransplant diabetes mellitus after orthotopic liver transplantation. Transplant Proc 2002;34(5):1571–1572.

    Article  Google Scholar 

  24. Sumrani NB, et al. Diabetes mellitus after renal transplantation in the cyclosporine era–an analysis of risk factors. Transplantation 1991;51(2):343–347.

    Article  CAS  Google Scholar 

  25. Vesco L, et al. Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors. Transplantation 1996;61(10):1475–1478.

    Article  CAS  Google Scholar 

  26. Markell M. Clinical impact of posttransplant diabetes mellitus. Transplant Proc 2001;33(5A Suppl):19S–22S.

    Article  CAS  Google Scholar 

  27. Seagraves A, et al. Net protein catabolic rate after kidney transplantation: impact of corticosteroid immunosuppression. JPEN J Parenter Enteral Nutr 1986;10(5):453–455.

    Article  CAS  Google Scholar 

  28. Wilkinson A, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005;19(3):291–298.

    Article  Google Scholar 

  29. Weir MR, Fink JC. Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999;34(1):1–13.

    Article  CAS  Google Scholar 

  30. Davidson J, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003;5(10 Suppl):S3–24.

    Google Scholar 

  31. Hricik DE. Steroid-free immunosuppression in kidney transplantation: an editorial review. Am J Transplant 2002;2(1):19–24.

    Article  Google Scholar 

  32. Moons P, et al. Symptom experience associated with maintenance immunosuppression after heart transplantation: patients' appraisal of side effects. Heart Lung 1998;27(5):315–325.

    Article  CAS  Google Scholar 

  33. Prasad GV, et al. Renal transplant recipient attitudes toward steroid use and steroid withdrawal. Clin Transplant 2003;17(2):135–139.

    Article  Google Scholar 

  34. Greig P, et al. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up. Liver Transpl 2003;9(6):587–595.

    Article  Google Scholar 

  35. Jaber JJ, et al. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Clin Transplant 2007;21(1):101–109.

    Article  Google Scholar 

  36. Kneteman NM. Steroid-free immunosuppression: balancing efficacy and toxicity. Liver Transpl 2001;7(8):698–700.

    Article  CAS  Google Scholar 

  37. Fabrega AJ, et al. Long-term (24-month) follow-up of steroid withdrawal in renal allograft recipients with posttransplant diabetes mellitus. Transplantation 1995;60(12):1612–1614.

    CAS  Google Scholar 

  38. Hricik DE, et al. The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients. Transplantation 1992;54(5):868–871.

    Article  CAS  Google Scholar 

  39. Hricik DE, et al. Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 1991;51(2):374–377.

    Article  CAS  Google Scholar 

  40. Midtvedt K, et al. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 2004;15(12):3233–3239.

    Article  Google Scholar 

  41. Sivaraman P, Nussbaumer G, Landsberg D. Lack of long-term benefits of steroid withdrawal in renal transplant recipients. Am J Kidney Dis 2001;37(6):1162–1169.

    Article  CAS  Google Scholar 

  42. Rogers CC, et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation 2005;80(1):26–33.

    Article  CAS  Google Scholar 

  43. van den Ham EC, et al. The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients. Transpl Int, 2003;16(2):82–87.

    Article  Google Scholar 

  44. Vitko S, et al. Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study. Transplantation 2005;80(12):1734–1741.

    Article  CAS  Google Scholar 

  45. Woodle ES. A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: one year report. Transplant Proc 2005;37(2):804–808.

    Article  CAS  Google Scholar 

  46. Hricik DE, et al. Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients. Transplantation 1992;53(6):1232–1235.

    Article  CAS  Google Scholar 

  47. ter Meulen CG, et al. No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study. Transplantation 2004;78(1):101–106.

    Article  Google Scholar 

  48. van den Ham EC, et al. Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy. Transpl Int 2003;16(5):300–306.

    Article  Google Scholar 

  49. Augustine JJ, Hricik DE. Steroid sparing in kidney transplantation: changing paradigms, improving outcomes, and remaining questions. Clin J Am Soc Nephrol 2006;1(5):1080–1089.

    Article  CAS  Google Scholar 

  50. Laftavi MR, et al. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety. Surgery 2005;137(3):364–371.

    Article  Google Scholar 

  51. Luke RG. Pathophysiology and treatment of posttransplant hypertension. J Am Soc Nephrol 1991;2(2 Suppl 1):S37–44.

    CAS  Google Scholar 

  52. Miller LW. Long-term complications of cardiac transplantation. Prog Cardiovasc Dis 1991;33(4):229–282.

    Article  CAS  Google Scholar 

  53. Monsour HP, et al. Renal insufficiency and hypertension as long-term complications in liver transplantation. Semin Liver Dis 1995;15(2):123–132.

    Article  Google Scholar 

  54. Textor SC, et al. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl 2000;6(5):521–530.

    Article  CAS  Google Scholar 

  55. Canzanello VJ, et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997;3(1):1–9.

    Article  CAS  Google Scholar 

  56. Dussol B, et al. Acute transplant artery thrombosis induced by angiotensin-converting inhibitor in a patient with renovascular hypertension. Nephron 1994;66(1):102–104.

    Article  CAS  Google Scholar 

  57. Garcia TM, et al. Acute tubular necrosis in kidney transplant patients treated with enalapril. Ren Fail 1994;16(3):419–423.

    Article  CAS  Google Scholar 

  58. Knight RJ, Kahan BD. The place of sirolimus in kidney transplantation: can we reduce calcineurin inhibitor renal toxicity? Kidney Int 2006;70(6):994–999.

    Article  CAS  Google Scholar 

  59. Kahan BD, Camardo JS. Rapamycin: clinical results and future opportunities. Transplantation 2001;2(7):1181–1193.

    Article  Google Scholar 

  60. Kahan BD. Sirolimus-based immunosuppression: present state of the art. J Nephrol 2004;17 Suppl 8:S32–39.

    CAS  Google Scholar 

  61. Hoogeveen RC, et al. Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients. Transplantation 2001;72(7):1244–1250.

    Article  CAS  Google Scholar 

  62. Davidson MH. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 2006;98(4A):27i–33i.

    Article  CAS  Google Scholar 

  63. Gautam A. Gastrointestinal complications following transplantation. Surg Clin North Am 2006;86(5):1195–1206.

    Article  Google Scholar 

  64. Weiner DE. Causes and consequences of chronic kidney disease: implications for managed health care. J Manag Care Pharm 2007;13(3 Suppl):S1–9.

    Google Scholar 

  65. Martins C, Pecoits-Filho R, Riella MC. Nutrition for the post-renal transplant recipients. Transplant Proc 2004;36(6):1650–1654.

    Article  CAS  Google Scholar 

  66. van den Ham EC, Kooman JP, van Hooff JP. Nutritional considerations in renal transplant patients. Blood Purif 2002;20(2):139–144.

    Article  Google Scholar 

  67. Dimeny E, et al. The role of lipoprotein abnormalities in chronic vascular rejection after kidney transplantation. Transplant Proc 1995;27(3):2036–2039.

    CAS  Google Scholar 

  68. Patel MG. The effect of dietary intervention on weight gains after renal transplantation. J Ren Nutr 1998;8(3):137–141.

    Article  CAS  Google Scholar 

  69. Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome – the heart of the matter. Nephrol Dial Transplant 2002;17 Suppl 11:28–31.

    Google Scholar 

  70. Gore JL, et al. Obesity and outcome following renal transplantation. AJT 2006;6:357–363.

    Article  CAS  Google Scholar 

  71. Chang SH, et al. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation 2007;84(8):981–987.

    Article  Google Scholar 

  72. Kent PS. Issues of obesity in kidney transplantation. J Ren Nutr 2007;17(2):107–113.

    Article  Google Scholar 

  73. Hasse J. Pretransplant obesity: a weighty issue affecting transplant candidacy and outcomes. Nutr Clin Pract 2007;22(5):494–504.

    Article  Google Scholar 

  74. Lochs H, Plauth M. Liver cirrhosis: rationale and modalities for nutritional support – the European Society of Parenteral and Enteral Nutrition consensus and beyond. Curr Opin Clin Nutr Metab Care 1999;2(4):345–349.

    Article  CAS  Google Scholar 

  75. Sanchez AJ, Aranda-Michel J. Nutrition for the liver transplant patient. Liver Transpl 2006;12(9):1310–1316.

    Article  Google Scholar 

  76. Richardson RA, et al. Influence of the metabolic sequelae of liver cirrhosis on nutritional intake. Am J Clin Nutr 1999;69(2):331–337.

    CAS  Google Scholar 

  77. Harrison J, McKiernan J, Neuberger JM. A prospective study on the effect of recipient nutritional status on outcome in liver transplantation. Transpl Int 1997;10(5):369–374.

    Article  CAS  Google Scholar 

  78. Pikul J, et al. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation 1994;57(3):469–472.

    Article  CAS  Google Scholar 

  79. Porayko MK, DiCecco S, O'Keefe SJ. Impact of malnutrition and its therapy on liver transplantation. Semin Liver Dis 1991;11(4):305–314.

    Article  CAS  Google Scholar 

  80. Janczewska I, Ericzon BG, Eriksson LS. Influence of orthotopic liver transplantation on serum vitamin A levels in patients with chronic liver disease. Scand J Gastroenterol 1995;30(1):68–71.

    Article  CAS  Google Scholar 

  81. Pescovitz MD, et al. Zinc deficiency and its repletion following liver transplantation in humans. Clin Transplant 1996;10(3):256–260.

    CAS  Google Scholar 

  82. Stegall MD, et al. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation 1995;60(9):1057–1060.

    CAS  Google Scholar 

  83. Millonig G, et al. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study. Liver Transpl 2005;11(8):960–966.

    Article  Google Scholar 

  84. Sutherland DE, Gruessner, AC. Long-term results after pancreas transplantation. Transplant Proc 2007;39(7):2323–2325.

    Article  CAS  Google Scholar 

  85. Katz H, et al. Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 1991;325(18):1278–1283.

    Article  CAS  Google Scholar 

  86. Obayashi, P. Adult pancreas transplantation. In: Hasse J, Blue L, eds. Comprehensive Guide to Transplant Nutrition. Chicago, IL: American Diabetic Association, 2002:90–105.

    Google Scholar 

  87. Pahwa N, Hedberg A. Adult heart and lung transplantation. In: Hasse J, Blue L, eds. Comprehensive Guide to Transplant Nutrition. Chicago, IL: American Diabetic Association. 2002:31–43.

    Google Scholar 

  88. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002;26(1 Suppl):1SA–138SA (Errata 2002;26:144).

    Google Scholar 

  89. Berger MM, Mustafa, I. Metabolic and nutritional support in acute cardiac failure. Curr Opin Clin Nutr Metab Care 2003;6(2):195–201.

    Article  CAS  Google Scholar 

  90. Frazier OH, et al. Nutritional management of the heart transplant recipient. J Heart Transplant 1985;4(4):450–452.

    CAS  Google Scholar 

  91. Lietz K, et al. Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation 2001;2(2):277–283.

    Article  Google Scholar 

  92. Gonzalez-Castro A, et al. Influence of nutritional status in lung transplant recipients. Transplant Proc 2006;38(8):2539–2540.

    Article  CAS  Google Scholar 

  93. Sodhi SS, et al. Gastroparesis after combined heart and lung transplantation. J Clin Gastroenterol 2002;34(1):34–39.

    Article  CAS  Google Scholar 

  94. Niv Y, Mor E, Tzakis, AG. Small bowel transplantation – a clinical review. Am J Gastroenterol 1999;94(11):3126–3130.

    CAS  Google Scholar 

  95. Middleton SJ. Is intestinal transplantation now an alternative to home parenteral nutrition? Proc Nutr Soc 2007;66(3):316–320.

    Article  Google Scholar 

  96. Grant D, et al. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg 2005;241(4):607–613.

    Article  Google Scholar 

  97. Chang EB. Intestinal water and electrolyte absorption and secretion. Transplant Proc 1996;28(5):2679–2682.

    CAS  Google Scholar 

  98. Weseman RA, Gilroy, R. Nutrition management of small bowel transplant patients. Nutr Clin Pract 2005;20(5):509–516.

    Article  Google Scholar 

  99. Pakarinen M, Kuusanmaki P, Halttunen, J. Recovery of fat absorption in the transplanted ileum. Transplant Proc 1994;26(3):1665–1666.

    CAS  Google Scholar 

  100. Nishida S, et al. Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients. Transplant Proc 2006;38(6):1747–1749.

    Article  CAS  Google Scholar 

  101. Yabu JM, Vincenti, F. Novel immunosuppression: small molecules and biologics. Semin Nephrol 2007;27(4):479–486.

    Article  CAS  Google Scholar 

  102. Tedesco Silva H, et al. Immunotherapy for De Novo renal transplantation: what's in the pipeline? Drugs 2006;66(13):1665–1684.

    Article  Google Scholar 

  103. Fudaba Y, et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant 2006;6(9):2121–2133.

    Article  CAS  Google Scholar 

  104. Weiss MJ, Ng CY, Madsen, JC. Tolerance, xenotransplantation: future therapies. Surg Clin North Am 2006;86(5):1277–1296.

    Article  Google Scholar 

  105. Sykes M. Immune tolerance: mechanisms and application in clinical transplantation. J Intern Med 2007;262(3):288–310.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Johns Hopkins Hospital, Baltimore, MD, USA

    Matthew J. Weiss MD

  2. Thomas Jefferson University, Philadelphia, PA, USA

    Vincent T. Armenti MD, PHD (Professor of Pathology, Anatomy and Cell Biology, Professor of Surgery)

  3. Temple University, School of Pharmacy, Philadelphia, PA, USA

    Nicole Sifontis PHARMD, BCPS (Associate Professor of Pharmacy)

  4. Baylor Institute of Transplantation Sciences, Baylor University Medical Center, Dallas, TX, USA

    Jeanette M. Hasse PHD, RD, FADA, CNSD

Authors
  1. Matthew J. Weiss MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincent T. Armenti MD, PHD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicole Sifontis PHARMD, BCPS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeanette M. Hasse PHD, RD, FADA, CNSD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Nursing, University of Pennsylvania, Guardian Dr. 420, Philadelphia, 19104, U.S.A.

    Joseph I. Boullata

  2. Dept. Surgery, Temple University Hospital, N. Broad St. 3401, Philadelphia, 19140, U.S.A.

    Vincent T. Armenti

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Weiss, M.J., Armenti, V.T., Sifontis, N., Hasse, J.M. (2009). Drug–Nutrient Interactions in Transplantation. In: Boullata, J., Armenti, V. (eds) Handbook of Drug-Nutrient Interactions. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-60327-362-6_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-362-6_25

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-363-3

  • Online ISBN: 978-1-60327-362-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation